Novo Holdings makes its first investment in an Asian health tech company

According to an announcement from Novo Holdings, the Danish holding company has joined the US$ 80 million Series C financing in Halodoc, an Indonesia-based health tech platform, media PR Newswire reports.

The health tech platform Halodoc was led by PT Astra Digital Internasional, a subsidiary of PT Astra International Tbk (Astra), and joined by existing and new investors including Temasek, Telkomsel’s TMI, Acrew Diversify Capital Fund, Bangkok Bank, UOB Venture Management, Singtel Innov8, BliBli, Allianz X, and Openspace Ventures.

Novo Holdings is the Novo Nordisk Foundation’s wholly-owned holding company for Novo Nordisk A/S and Novozymes A/S. This is the first investment by the Novo Holdings Asian life sciences team in Singapore following its setup last year.

The funds will be used to deepen Halodoc’s penetration in key healthcare verticals across Indonesia, improving patient experiences with technology-based solutions for the country’s most pressing healthcare problems.

Mette Larsen

About Mette Larsen

ScandAsia Journalist • Scandinavian Publishing Co., Ltd. • Thailand

View all posts by Mette Larsen